This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Solazyme Appoints Peter Kovacs, Former President And CEO Of NutraSweet Kelco, To Board Of Directors

Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, announced today the appointment of Peter Kovacs to the company’s Board of Directors. Mr. Kovacs brings over 45 years of food, specialty chemical, and industrial biotechnology experience to the company and has been a member of Solazyme’s Strategic Advisory Board since 2007.

“Peter brings a wealth of knowledge in the commercialization of new technologies including biotechnologies into our key markets, including nutrition and industrial and personal care chemicals,” said Jonathan Wolfson, CEO, Solazyme. “As we move into this next phase of commercialization, we welcome the expertise and guidance that Peter will provide as a board member, having already benefited from years of his expertise as an advisor.”

Mr. Kovacs joined the Kelco Company, a San Diego-based industrial biotechnology and specialty chemicals manufacturer and a Division of Merck & Co. Inc., as a laboratory chemist in 1967. After a series of domestic and international technical and business assignments, Mr. Kovacs was appointed President and CEO of the company in 1993, leading the sale of Kelco from Merck to Monsanto in 1994. He was subsequently chosen to join the Monsanto Operating Council and led the integration of the NutraSweet Company with Kelco, forming an $800 million food and industrial ingredient firm, which became one of the largest industrial biotechnology companies, the NutraSweet Kelco Company. He then served as President and CEO of NutraSweet Kelco until his retirement in 1997 after 30 years of service.

About Solazyme:

Solazyme, Inc. is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value tailored oils. Headquartered in South San Francisco, Solazyme’s renewable products can replace or enhance oils derived from the world’s three existing sources – petroleum, plants and animal fats. Initially, Solazyme is focused on commercializing its products into three target markets: (1) fuels and chemicals, (2) nutrition and (3) skin and personal care. Solazyme's oils and fuels provide compelling solutions to increasingly complex issues of fuel scarcity, energy security and environmental impact while fitting into the pre-existing multi-trillion dollar fuel infrastructure.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs